Trupanion (NASDAQ:TRUP) CEO Margaret Tooth Sells 1,000 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 1,000 shares of Trupanion stock in a transaction that occurred on Friday, October 9th. The stock was sold at an average price of $25.84, for a total value of $25,840.00. Following the sale, the chief executive officer directly owned 184,952 shares of the company’s stock, valued at approximately $4,779,159.68. The trade was a 0.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Friday, September 11th, Margaret Tooth sold 1,000 shares of Trupanion stock. The shares were sold at an average price of $25.00, for a total value of $25,000.00.
• On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The shares were sold at an average price of $31.84, for a total value of $15,633.44.
• On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total value of $28,410.90.

Trupanion Stock Up 1.1%

TRUP stock opened at $26.57 on Wednesday. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of 49.60, a PEG ratio of 1.80 and a beta of 1.44. The business’s fifty day moving average price is $26.99 and its two-hundred day moving average price is $25.51. Trupanion, Inc. has a fifty-two week low of $21.16 and a fifty-two week high of $46.98.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. The company’s revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.22 earnings per share. On average, equities analysts anticipate that Trupanion, Inc. will post 0.63 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Kelleher Financial Advisors acquired a new stake in shares of Trupanion during the 2nd quarter worth approximately $42,000. Parallel Advisors LLC raised its position in Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares in the last quarter. Quantbot Technologies LP acquired a new position in Trupanion during the second quarter valued at approximately $89,000. Fifth Third Bancorp raised its position in Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after purchasing an additional 7,336 shares in the last quarter. Finally, Arizona State Retirement System raised its position in Trupanion by 7.7% during the second quarter. Arizona State Retirement System now owns 9,587 shares of the financial services provider’s stock valued at $237,000 after purchasing an additional 688 shares in the last quarter.

Analyst Upgrades and Downgrades

Several analysts have weighed in on TRUP shares. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $45.00 to $32.00 in a research note on Wednesday, August 26th. Cantor Fitzgerald decreased their target price on shares of Trupanion from $34.00 to $30.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 7th. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research report on Wednesday, July 15th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Finally, Stifel Nicolaus lifted their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Thursday, August 20th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $38.40.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.

The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.

Founded in 2000, Trupanion is headquartered in Seattle, Washington.